⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ELUT News
Elutia Inc. Class A Common Stock
Form 8-K
sec.gov
ELUT
Elutia Regains Compliance with Nasdaq Listing Requirements
globenewswire.com
ELUT
Elutia Selects Pete Ligotti as CCO to Lead the Commercial Launch of NXT-41x and Transform Post-Mastectomy Care in the $1.5B U.S. Breast Surgery Market
globenewswire.com
ELUT
Elutia to Report Fourth Quarter 2025 Financial Results on Wednesday, March 11, 2026
globenewswire.com
ELUT
Where Purpose Meets Performance: Elutia Earns 2026 Great Place to Work Certification™
globenewswire.com
ELUT
Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, and Upcoming NXT-41x Milestones
globenewswire.com
ELUT
Elutia to Present at Global BioInnovation Forum on NXT-41x Biomatrix Program for Plastic and Reconstructive Surgery
globenewswire.com
ELUT
Elutia Reports Third Quarter 2025 Financial Results; Closes $88 Million Sale of BioEnvelope Business to Boston Scientific Corporation; Funds NXT-41x Development
globenewswire.com
ELUT
Elutia to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
globenewswire.com
ELUT
Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21
globenewswire.com
ELUT